Actinium re-elects Shetty and Almenoff as Class III directors at 2025 annual meeting

Actinium Pharmaceuticals, Inc.

Shetty elected with 5,032,369 for, 1,234,852 withheld; Almenoff with 5,284,503 for, 982,719 withheld.
Ratification of CBIZ as auditor: 13,724,478 for, 1,537,998 against, 232,097 abstain.
Non-binding advisory vote on executive compensation approved: 4,481,875 for, 1,541,460 against.
Advisory vote on frequency of say-on-pay: 1-year interval received most votes (4,645,270).
Total shares present: 15,494,573 of 31,195,891 outstanding; all proposals approved.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.